Clinical Usage and Potential Benefits of a Continuous Glucose Monitoring Predict App
Continuous glucose monitoring (CGM) has become an increasingly important tool for self-management in people with diabetes mellitus (DM). In this paper, we discuss recommendations on how to implement predictive features provided by the Accu-Chek SmartGuide Predict app in clinical practice. The Predict app's features are aimed at ultimately reducing diabetes stress and fear of hypoglycemia in people with DM. Furthermore, we explore the use cases and potential benefits of continuous glucose prediction, predictions of low glucose, and nocturnal hypoglycemia.
Authors
- Dominic Ehrmann (ORCID: https://orcid.org/0000-0002-5794-5596)
- Timor Glatzer (ORCID: https://orcid.org/0009-0009-5644-2098)
- Bernhard Gehr
- Gabriela Bucklar
- Miriam Stangs
- Nora Wolf (ORCID: https://orcid.org/0009-0002-1602-179X)
- María Teresa Martínez
- Joannet Onvlee
- Michèle Hofer
Institutions
- Roche (Switzerland) (CH)
- Radboud University Nijmegen (NL)
- German Diabetes Center Mergentheim (DE)
- Radboud University Medical Center (NL)
- Hospital Universitari i Politècnic La Fe (ES)
- Forschungsinstitut der Diabetes Akademie Mergentheim (DE)
Publication Details
- Journal
- Journal of Diabetes Science and Technology
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1177/19322968241268353
- Citations
- 12
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 4.29
Funders
- Roche Diabetes Care